Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Prexige Still Postponed: Novartis To Resubmit COX-2 Inhibitor In U.S. In 2007

Nov 13 2006

• By Jessica Merrill

Related Content

FDA Discloses Safety Reviews Of COX-2s Arcoxia, Prexige and Parecoxib

Feb 14 2005

Prexige TARGET Study: Not Quite A Bull’s-Eye For Novartis

Aug 23 2004

Mobic May Gain Momentum After Bextra Withdrawal

Apr 11 2005

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window